scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.YJMCC.2015.04.019 |
P698 | PubMed publication ID | 25939780 |
P2093 | author name string | Jun Wu | |
Ren-Ke Li | |||
Richard D Weisel | |||
Shu-Hong Li | |||
Kota Hatta | |||
Zhengbo Shao | |||
Huifang Song | |||
Nathan C Ni | |||
Mansoreh Nazari | |||
Ana Ludke | |||
P2860 | cites work | Putative stem cell activity of human endometrial epithelial and stromal cells during the menstrual cycle | Q57250342 |
Downregulation of beta2-microglobulin in human cord blood somatic stem cells after transplantation into livers of SCID-mice: an escape mechanism of stem cells? | Q74326208 | ||
CNS immune privilege: hiding in plain sight | Q24642697 | ||
Cell therapy for heart failure: a comprehensive overview of experimental and clinical studies, current challenges, and future directions | Q27001159 | ||
The testis in immune privilege | Q28263610 | ||
Pluripotency of mesenchymal stem cells derived from adult marrow | Q29617959 | ||
Adult cardiac stem cells are multipotent and support myocardial regeneration | Q29620122 | ||
Identification of Lin(-)Sca1(+)kit(+)CD34(+)Flt3- short-term hematopoietic stem cells capable of rapidly reconstituting and rescuing myeloablated transplant recipients. | Q31133190 | ||
Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function | Q33863225 | ||
Stem cell factor: biology and relevance to clinical practice | Q34313859 | ||
Stem cell factor receptor induces progenitor and natural killer cell-mediated cardiac survival and repair after myocardial infarction. | Q34479264 | ||
Is stem cell therapy ready for patients? Stem Cell Therapy for Cardiac Repair. Ready for the Next Step . | Q34550669 | ||
Ocular immune privilege: the eye takes a dim but practical view of immunity and inflammation | Q35186813 | ||
Derivation of insulin producing cells from human endometrial stromal stem cells and use in the treatment of murine diabetes | Q35568544 | ||
Current status of cellular therapy for ischemic heart disease | Q36141024 | ||
Cardiac progenitor cells from adult myocardium: Homing, differentiation, and fusion after infarction | Q36349782 | ||
Enhanced effect of combining human cardiac stem cells and bone marrow mesenchymal stem cells to reduce infarct size and to restore cardiac function after myocardial infarction | Q36630155 | ||
Immunology of pregnancy: cellular mechanisms allowing fetal survival within the maternal uterus | Q36802749 | ||
Immune privilege and the skin | Q37156222 | ||
Aging and disease as modifiers of efficacy of cell therapy | Q37183949 | ||
Vasculogenesis and angiogenesis in the endometrium during menstrual cycle and implantation | Q37501370 | ||
Sex hormones and coronary disease: a review of the clinical studies | Q37989456 | ||
Challenges in allogeneic mesenchymal stem cell-mediated cardiac repair. | Q37995409 | ||
Regulatory immune cells in transplantation | Q38013048 | ||
The immune privilege of testis and gravid uterus: same difference? | Q38146307 | ||
Myometrial cells induce angiogenesis and salvage damaged myocardium. | Q38483643 | ||
Evolving trends in the epidemiologic factors of heart failure: rationale for preventive strategies and comprehensive disease management | Q41513063 | ||
Differentiation of allogeneic mesenchymal stem cells induces immunogenicity and limits their long-term benefits for myocardial repair | Q42794686 | ||
Temporal dynamics of cardiac immune cell accumulation following acute myocardial infarction | Q43733452 | ||
Cardiac side population cells and Sca-1-positive cells | Q44231631 | ||
Adult cardiac Sca-1-positive cells differentiate into beating cardiomyocytes | Q44710997 | ||
Increasing donor age adversely impacts beneficial effects of bone marrow but not smooth muscle myocardial cell therapy | Q46748172 | ||
An adult uterine hemangioblast: evidence for extramedullary self-renewal and clonal bilineage potential | Q47585419 | ||
Further characterization of CD34-low/negative mouse hematopoietic stem cells. | Q51089632 | ||
Uterine cells are recruited to the infarcted heart and improve cardiac outcomes in female rats. | Q51351109 | ||
P304 | page(s) | 116-128 | |
P577 | publication date | 2015-05-01 | |
P1433 | published in | Journal of Molecular and Cellular Cardiology | Q2061932 |
P1476 | title | Uterine-derived progenitor cells are immunoprivileged and effectively improve cardiac regeneration when used for cell therapy. | |
P478 | volume | 84 |
Search more.